Stopped: majority of the participants had exclusion criteria of anticoagulant use
This is a pilot randomized controlled trial (RCT) to gain preliminary evidence regarding the acceptability, tolerability, safety, and efficacy of a combined intervention of Stellate Ganglion Blockade (SGB) and psychoeducation on trauma symptoms and health behaviors in patients exhibiting early PTSD symptoms after cardiac arrest (CA). Primary Aim 1 (Feasibility outcomes): Gain preliminary evidence regarding the acceptability, tolerability, and safety of conducting a randomized trial that evaluates a single SGB treatment in conjunction with psychoeducation among CA patients with early PTSD symptoms. Secondary Aim 1 (Treatment-related outcomes): Test, whether SGB/psychoeducation treatment in CA patients with clinically significant PTSD symptoms is associated with reduced cardiac anxiety, PTSD symptoms, and improved health behaviors (physical activity and sleep duration), assessed objectively by a wrist-worn accelerometer for 4 weeks post-discharge.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Proportion of Eligible Subjects Who Get Enrolled in the Trial
Timeframe: Baseline (pre-procedure)
Number of Patients Recruited Per Month
Timeframe: Assessed at 10 Month from the beginning of enrollment
Proportion of Participants Who Complete the 4-weeks Assessments
Timeframe: 4 weeks post-enrollment
Proportion of Participants Who Complete the 12-weeks Assessments
Timeframe: 12-weeks post-procedure
Horner's Syndrome
Timeframe: Immediately post-procedure
Treatment Expectancy Eligibility Questionnaire
Timeframe: Immediately post-procedure
The Proportion of Participants Completing the Check-list of Various Components of Psychoeducation
Timeframe: Assessed at baseline post-procedure
Total Actigraph Wear Time
Timeframe: Assessed at 4-weeks post-procedure